Abstract | OBJECTIVE: METHODS: RESULTS: CONCLUSIONS: The striking difference in PD-ECGF/TP concentrations between SCLC and NSCLC suggests that these two types of lung cancer use alternative pathways for angiogenesis. The present study suggests that inhibitors of PD-ECGF/TP, which have been recently developed and are under laboratory investigation to test their effectiveness as treatments for various types of cancer, may not be effective against SCLC.
|
Authors | J Yamashita, M Ogawa, M Abe, M Nishida |
Journal | Chest
(Chest)
Vol. 116
Issue 1
Pg. 206-11
(Jul 1999)
ISSN: 0012-3692 [Print] United States |
PMID | 10424527
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Aged
- Carcinoma, Non-Small-Cell Lung
(blood supply, metabolism)
- Carcinoma, Small Cell
(blood supply, metabolism)
- Enzyme-Linked Immunosorbent Assay
- Female
- Humans
- Lung
(blood supply)
- Lung Neoplasms
(blood supply, metabolism)
- Male
- Neovascularization, Pathologic
- Thymidine Phosphorylase
(metabolism)
|